Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-31

Clinical Trial Update: Effect of Different Frequencies of Umbilical Cord-mesenchymal Stem Cells Through Peripheral Vein in Patients With ESLD [NA]

View source ↗

Summary

This clinical trial evaluated different frequencies of intravenous administration of umbilical cord-derived mesenchymal stem cells in patients with end-stage li…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Umbilical cord-derived mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: General Hospital of Shenyang Military Region | Conditions: End-Stage Liver DIsease | NA | Status: COMPLETED